The signal pathways and treatment of cytokine storm in COVID-19
L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …
and is more devastating than any other previous infectious disease. It has affected a …
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond
J Rimando, SR McCurdy, L Luznik - Blood, 2023 - ashpublications.org
Advances in conditioning, graft-versus-host disease (GVHD) prophylaxis and antimicrobial
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …
Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies
In search of an ideal partner or alternative to conventional immunosuppressive agents,
rabbit anti-thymocyte globulin (ATG) and, more recently, post-transplant cyclophosphamide …
rabbit anti-thymocyte globulin (ATG) and, more recently, post-transplant cyclophosphamide …
Cytokine release syndrome in the immunotherapy of hematological malignancies: The biology behind and possible clinical consequences
THA Tvedt, AK Vo, Ø Bruserud, H Reikvam - Journal of Clinical Medicine, 2021 - mdpi.com
Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome
characterized by fever and multiple organ dysfunction associated with (i) chimeric antigen …
characterized by fever and multiple organ dysfunction associated with (i) chimeric antigen …
[HTML][HTML] State of the CAR-T: risk of infections with chimeric antigen receptor T-cell therapy and determinants of SARS-CoV-2 vaccine responses
Chimeric antigen receptor T cell (CAR-T) therapy has shown unprecedented response rates
in patients with relapsed/refractory (R/R) hematologic malignancies. Although CAR-T …
in patients with relapsed/refractory (R/R) hematologic malignancies. Although CAR-T …
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis
R Abboud, F Wan, J Mariotti, M Arango… - Bone Marrow …, 2021 - nature.com
Haploidentical related donor transplantation (haplo-HCT) is associated with cytokine
release syndrome (CRS). We conducted a multicenter retrospective study to analyze risk …
release syndrome (CRS). We conducted a multicenter retrospective study to analyze risk …
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies
Allogeneic blood and marrow transplantation (alloBMT) is increasingly being used in older
patients with blood cancer. Aging is associated with an increasing incidence of clonal …
patients with blood cancer. Aging is associated with an increasing incidence of clonal …
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
L Xia, L Yuan, Y Hu, J Liu, G Hu, R Qi… - Cellular & Molecular …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced cytokine storm is
closely associated with coronavirus disease 2019 (COVID-19) severity and lethality …
closely associated with coronavirus disease 2019 (COVID-19) severity and lethality …
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic …
S Harbi, L Brac de la Perriere, B Bouchacourt… - Bone Marrow …, 2024 - nature.com
Haploidentical stem cell transplantation (Haplo-SCT) using non-myeloablative conditioning
regimen (NMAC) has extended the feasibility of allogeneic transplantation, notably in older …
regimen (NMAC) has extended the feasibility of allogeneic transplantation, notably in older …
The many faces of cytokine release syndrome-related coagulopathy
J Wang, J Doran - Clinical Hematology International, 2021 - Springer
Cytokine release syndrome (CRS) has been increasingly recognized in various conditions
including the coronavirus disease 2019 (COVID-19). It is not only associated with systemic …
including the coronavirus disease 2019 (COVID-19). It is not only associated with systemic …